Minerva Surgical, Inc.

UTRS · OTC
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Operating Activities
Net Income-$7,181-$8,681-$11,343-$6,245
Dep. & Amort.$1,446$1,983$2,514$2,753
Deferred Tax$103$0$0$0
Stock-Based Comp.$833$1,098$1,274$1,802
Change in WC-$775-$3,983-$1,056-$9,201
Other Non-Cash$479-$25$225-$4,753
Operating Cash Flow-$5,095-$9,608-$8,386-$15,644
Investing Activities
PP&E Inv.-$17-$13-$75$36
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$16
Investing Cash Flow-$17-$13-$75$52
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$26,774$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$79$0$0
Financing Cash Flow$0$79$26,774$2
Forex Effect$0$0$0$0
Net Chg. in Cash-$5,112-$9,542$18,313-$15,590
Supplemental Information
Beg. Cash$16,582$26,124$7,811$23,401
End Cash$11,470$16,582$26,124$7,811
Free Cash Flow-$5,112-$9,621-$8,461-$15,608